Key points are not available for this paper at this time.
Design
Editorial
The author highlights blind spots in the new International Society of Hypertension guidelines, specifically advocating for physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping and amiloride for the Liddle phenotype.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
J. David Spence (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: